Epithelial ovarian cancer relapsing as isolated lymph node disease: natural history and clinical outcome

per Legge, Francesco, Petrillo, Marco, Adamo, Vincenzo, Pisconti, Salvatore, Scambia, Giovanni, Ferrandina, Gabriella
Publicat 2008

Efficacy of nab-paclitaxel plus trastuzumab in a long-surviving heavily pretreated HER2-positive breast cancer patient with brain metastases

per Ricciardi, Giuseppina Rosaria Rita, Russo, Alessandro, Franchina, Tindara, Ferraro, Giuseppa, Adamo, Vincenzo
Publicat a Onco Targets Ther (2015)

Heterogeneous Responses to Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors (TKIs) in Patients with Uncommon EGFR Mutations: New Insights and Future Perspectives...

per Russo, Alessandro, Franchina, Tindara, Ricciardi, Giuseppina, Battaglia, Alessandra, Picciotto, Maria, Adamo, Vincenzo
Publicat a Int J Mol Sci (2019)

Emerging Targeted Therapies for Castration-Resistant Prostate Cancer

per Adamo, Vincenzo, Noto, Laura, Franchina, Tindara, Chiofalo, Giuseppe, Picciotto, Maria, Toscano, Giuseppe, Caristi, Nicola
Publicat 2012

Nab-paclitaxel and trastuzumab combination: a promising approach for neoadjuvant treatment in HER2-positive breast cancer

per Ricciardi, Giuseppina Rosaria Rita, Franchina, Tindara, Russo, Alessandro, Schifano, Silvia, Ferraro, Giuseppa, Adamo, Vincenzo
Publicat a Onco Targets Ther (2016)

Prognostic value of androgen receptor expression in triple negative breast carcinomas: personal experience and comments on a review about “Triple-negative breast cancer: treatment...

per Ieni, Antonio, Barresi, Valeria, Ricciardi, Giuseppina Rosaria Rita, Adamo, Barbara, Adamo, Vincenzo, Tuccari, Giovanni
Publicat a Breast Cancer (Dove Med Press) (2016)

Long time response with chemotherapy in ROS1 NSCLC patient with unusual metastatic site

per Franchina, Tindara, Russo, Alessandro, Ricciardi, Giuseppina Rosaria, Liguori, Giuseppina, Herberg, Astrid, Normanno, Nicola, Adamo, Vincenzo
Publicat a Cancer Biol Ther (2016)

Efficacy of T-DM1 for leptomeningeal and brain metastases in a HER2 positive metastatic breast cancer patient: new directions for systemic therapy - a case report and literature re...

per Ricciardi, Giuseppina Rosaria Rita, Russo, Alessandro, Franchina, Tindara, Schifano, Silvia, Mastroeni, Giampiero, Santacaterina, Anna, Adamo, Vincenzo
Publicat a BMC Cancer (2018)

Peritoneal carcinomatosis of colorectal origin

per Macrì, Antonio, Saladino, Edoardo, Bartolo, Vincenzo, Adamo, Vincenzo, Altavilla, Giuseppe, Mondello, Epifanio, Condemi, Giovanni, Sinardi, Angelo, Famulari, Ciro
Publicat 2010

Influence of EGFR mutational status on metastatic behavior in non squamous non small cell lung cancer

per Russo, Alessandro, Franchina, Tindara, Ricciardi, Giuseppina Rosaria Rita, Fanizza, Caterina, Scimone, Antonino, Chiofalo, Giuseppe, Giordano, Antonio, Adamo, Vincenzo
Publicat a Oncotarget (2017)

Baseline neutrophilia, derived neutrophil‐to‐lymphocyte ratio (dNLR), platelet‐to‐lymphocyte ratio (PLR), and outcome in non small cell lung cancer (NSCLC) treated with Nivolumab o...

per Russo, Alessandro, Franchina, Tindara, Ricciardi, Giuseppina R.R., Battaglia, Alessandra, Scimone, Antonino, Berenato, Rosa, Giordano, Antonio, Adamo, Vincenzo
Publicat a J Cell Physiol (2018)

Induction chemotherapy with paclitaxel and cisplatin to concurrent radiotherapy and weekly paclitaxel in the treatment of loco-regionally advanced, stage IV (M0), head and neck squ...

per Pergolizzi Stefano, Santacaterina Anna, Adamo Barbara, Franchina Tindara, Denaro Nerina, Ferraro Pina, Ricciardi Giusy RR, Settineri Nicola, Adamo Vincenzo
Publicat 2011-11-01

Induction chemotherapy with paclitaxel and cisplatin to concurrent radiotherapy and weekly paclitaxel in the treatment of loco-regionally advanced, stage IV (M0), head and neck squ...

per Pergolizzi, Stefano, Santacaterina, Anna, Adamo, Barbara, Franchina, Tindara, Denaro, Nerina, Ferraro, Pina, Ricciardi, Giusy RR, Settineri, Nicola, Adamo, Vincenzo
Publicat 2011

Androgen Receptor (AR), E-Cadherin, and Ki-67 as Emerging Targets and Novel Prognostic Markers in Triple-Negative Breast Cancer (TNBC) Patients

per Ricciardi, Giuseppina Rosaria Rita, Adamo, Barbara, Ieni, Antonio, Licata, Luana, Cardia, Roberta, Ferraro, Giuseppa, Franchina, Tindara, Tuccari, Giovanni, Adamo, Vincenzo
Publicat a PLoS One (2015)

Correction: Androgen Receptor (AR), E-Cadherin, and Ki-67 as Emerging Targets and Novel Prognostic Markers in Triple-Negative Breast Cancer (TNBC) Patients

per Ricciardi, Giuseppina Rosaria Rita, Adamo, Barbara, Ieni, Antonio, Licata, Luana, Cardia, Roberta, Ferraro, Giuseppa, Franchina, Tindara, Tuccari, Giovanni, Adamo, Vincenzo
Publicat a PLoS One (2015)

A decade of EGFR inhibition in EGFR-mutated non small cell lung cancer (NSCLC): Old successes and future perspectives

per Russo, Alessandro, Franchina, Tindara, Rita Ricciardi, Giuseppina Rosaria, Picone, Antonio, Ferraro, Giuseppa, Zanghì, Mariangela, Toscano, Giuseppe, Giordano, Antonio, Adamo, Vincenzo
Publicat a Oncotarget (2015)

Immunoexpression of lactoferrin in triple-negative breast cancer patients: A proposal to select a less aggressive subgroup

per Ieni, Antonio, Barresi, Valeria, Licata, Luana, Cardia, Roberta, Fazzari, Carmine, Nuciforo, Giuseppe, Caruso, Francesco, Caruso, Michele, Adamo, Vincenzo, Tuccari, Giovanni
Publicat a Oncol Lett (2017)

The prognostic significance of combined androgen receptor, E-Cadherin, Ki67 and CK5/6 expression in patients with triple negative breast cancer

per Adamo, Barbara, Ricciardi, Giuseppina Rosaria Rita, Ieni, Antonio, Franchina, Tindara, Fazzari, Carmine, Sanò, Maria Vita, Angelico, Giuseppe, Michele, Caruso, Tuccari, Giovanni, Adamo, Vincenzo
Publicat a Oncotarget (2017)

Correction: The prognostic significance of combined androgen receptor, E-Cadherin, Ki67 and CK5/6 expression in patients with triple negative breast cancer

per Adamo, Barbara, Ricciardi, Giuseppina Rosaria Rita, Ieni, Antonio, Franchina, Tindara, Fazzari, Carmine, Sanò, Maria Vita, Angelico, Giuseppe, Caruso, Michele, Tuccari, Giovanni, Adamo, Vincenzo
Publicat a Oncotarget (2019)

An observational time and motion study of denosumab subcutaneous injection and zoledronic acid intravenous infusion in patients with metastatic bone disease: results from three Eur...

per Body, Jean-Jacques, Gatta, Francesca, De Cock, Erwin, Tao, Sunning, Kritikou, Persefoni, Wimberger, Pauline, Mebis, Jeroen, Peeters, Marc, Pedrazzoli, Paolo, Caraceni, Augusto, Adamo, Vincenzo, Hechmati, Guy
Publicat a Support Care Cancer (2017)